The Cigna Group (CI) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are...
The Cigna Group (CI) currently trades at a P/E ratio of 11.69 (historical range: 10.72–33.64, median: 15.84), placing it at the 11th percentile — cheap relative to its history, P/S ratio of 0.26 (range: 0.25–0.48, 9th percentile — cheap relative to its history), EV/EBITDA of 40.96 (range: 10.00–57.91, 73th percentile).
Over the historical period (2024-08-30 to 2026-08-28), The Cigna Group's P/E ratio has contracted by 48% over the observed period (from an average of 23.8 to 12.4).
The Cigna Group appears undervalued relative to its historical range, with most valuation metrics below their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 11.69 | 10.72 | 15.84 | 33.64 | 11th | cheap relative to its history |
| P/S Ratio | 0.26 | 0.25 | 0.31 | 0.48 | 9th | cheap relative to its history |
| EV/EBITDA | 40.96 | 10.00 | 22.86 | 57.91 | 73th | above its historical average |